Efficacy and Safety From a Phase 2B Trial of SM04690, a Novel, Intra-Articular, WNT Pathway Inhibitor for the Treatment of Osteoarthritis of the Knee

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.566

Related search